文献速递慢性肾脏病遗传性与小管间质肾病

多祖先蛋白组孟德尔随机化揭示细胞外蛋白、肾小管细胞和成纤维细胞参与eGFR调控

A novel multi-ancestry proteome-wide Mendelian randomization study implicates extracellular proteins, tubular cells, and fibroblasts in estimated glomerular filtration rate regulation.
PubMed 文献 · Kidney Int · 2023-09-27

研究在PURE研究12,066名多祖先参与者中,对1,161种血浆生物标志物进行蛋白组孟德尔随机化分析,结合已发表GWAS数据,发现22种生物标志物的遗传决定浓度与eGFR相关,其中5种为GWAS已识别,9种位于GWAS先导变异1 Mb内但基因未被确定为候选。单细胞转录组显示这些标志物表达于肾小管、集合管、成纤维细胞和免疫细胞,通路分析显示细胞外肾实质显著富集。

要点

  • 22种生物标志物的遗传改变浓度与eGFR相关,超过Bonferroni校正显著性阈值。
  • 5种(UMOD、FGF5、LGALS7、NINJ1、COL18A1)为GWAS已识别。
  • 9种位于GWAS先导变异1 Mb内但基因未被确定为GWAS信号候选。

核心结论

  • 通过蛋白组孟德尔随机化识别出22种可能以有益或不利方式因果影响eGFR的生物标志物。
  • 研究为eGFR新治疗靶点提供依据,并强调肾小管细胞和成纤维细胞产生的细胞外蛋白对eGFR的影响。

研究设计与样本

  • 蛋白组孟德尔随机化研究,在PURE研究12,066名多祖先参与者中检测1,161种血浆生物标志物浓度附近的遗传变异。
  • 采用两样本孟德尔随机化,将单个变异对生物标志物浓度的效应与已发表GWAS中eGFR和肾脏性状的效应进行相关分析。

主要发现

  • 22种生物标志物的遗传改变浓度与eGFR相关,超过Bonferroni校正显著性阈值。
  • 5种生物标志物(UMOD、FGF5、LGALS7、NINJ1、COL18A1)此前已被GWAS识别。
  • 9种生物标志物(INHBC、TNFRSF11A、TCN2、PXN1、PRTN3、PSMD9、TFPI、ITGB6、CA3)位于GWAS先导变异1 Mb内,但其基因未被确定为GWAS信号候选。
  • 单细胞转录组数据显示22种生物标志物表达于肾小管、集合管、成纤维细胞和免疫细胞。
  • 通路分析显示识别的生物标志物在细胞外肾实质显著富集。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Estimated glomerular filtration rate (eGFR) impacts the concentration of plasma biomarkers confounding biomarker association studies of eGFR with reverse causation. To identify biomarkers causally associated with eGFR, we performed a proteome-wide Mendelian randomization study. Genetic variants nearby biomarker coding genes were tested for association with plasma concentration of 1,161 biomarkers in a multi-ancestry sample of 12,066 participants from the Prospective Urban and Rural Epidemiological (PURE) study. Using two-sample Mendelian randomization, individual variants' effects on biomarker concentration were correlated with their effects on eGFR and kidney traits from published genome-wide association studies (GWAS). Genetically altered concentrations of 22 biomarkers were associated with eGFR above a Bonferroni-corrected significance threshold. Five biomarkers were previously identified by GWAS (UMOD, FGF5, LGALS7, NINJ1, COL18A1). Nine biomarkers were within 1 Mb of the lead GWAS variant but the gene for the biomarker was unidentified as the candidate for the GWAS signal (INHBC, TNFRSF11A, TCN2, PXN1, PRTN3, PSMD9, TFPI, ITGB6, CA3). Single-cell transcriptomic data indicated the 22 biomarkers are expressed in kidney tubules, collecting duct, fibroblasts, and immune cells. Pathway analysis showed significant enrichment of identified biomarkers in the extracellular kidney parenchyma. Thus, using genetic regulators of biomarker concentration via proteome-wide Mendelian randomization, we identified 22 biomarkers that appear to causally impact eGFR in either a beneficial or adverse manner. The current study provides rationale for novel therapeutic targets for eGFR and emphasized a role for extracellular proteins produced by tubular cells and fibroblasts for impacting eGFR.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Lanktree MB, Perrot N, Smyth A, et al. A novel multi-ancestry proteome-wide Mendelian randomization study implicates extracellular proteins, tubular cells, and fibroblasts in estimated glomerular filtration rate regulation. Kidney Int. 2023. PMID: 37774922. doi:10.1016/j.kint.2023.08.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。